• 1
    Nawa Y. Recent trends of Paragonimiasis westermani in Miyazaki Prefecture. Japan Southeast Asian J Trop Med Public Health 1991; 22: 3424.
  • 2
    Mukae H, Taniguchi H, Matsumoto N et al. Clinicoradiologic features of pleuropulmonary Paragonimus westermani on Kyusyu Island. Japan Chest 2001; 120: 51420.
  • 3
    Uchiyama F, Morimoto Y, Nawa Y. Re-emergence of paragonimiasis in Kyushu. Japan Southeast Asian J Trop Med Public Health 1999; 30: 68691.
  • 4
    Yokogawa M. Paragonimus and paragonimiasis. Adv Parasitol 1965; 3: 99158.
  • 5
    Miyazaki I, Hirose H. Immature lung flukes first found in the muscle of the wild boar in Japan. J Parasitol 1976; 62: 8367.
  • 6
    Finkelman FD, Pearce EJ, Urban JF Jr et al. Regulation and biological function of helminth-induced cytokine responses. Immunol Today 1991; 12: A626.
  • 7
    Hatano Y, Katagiri K, Ise T et al. Expression of Th1 and Th2 cytokine mRNAs    in    freshly    isolated    peripheral    blood    mononuclear    cells    of a patient with cutaneous paragonimiasis. J Dermatol Sci 1999; 19: 1447.
  • 8
    Taniguchi H, Mukae H, Matsumoto N et al. Elevated IL-5 levels in pleural fluid of patients with Paragonimiasis westermani. Clin Exp Immunol 2001; 123: 948.
  • 9
    Imai T, Yoshida T, Baba M et al. Molecular cloning of a novel T cell-directed CC chemokine expressed in thymus by signal sequence trap using Epstein–Barr virus vector. J Biol Chem 1996; 271: 2151421.
  • 10
    Imai T, Nagira M, Takagi S et al. Selective recruitment of CCR4-bearing Th2  cells  toward  antigen-presenting  cells  by  the  CC  chemokines ­thymus and activation-regulated chemokine and macrophage-derived chemokine. Int Immunol 1999; 11: 818.
  • 11
    Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996; 17: 13846.
  • 12
    Maruyama H, Noda S, Nawa Y. Emerging problems of parasitic diseases in southern Kyusyu. Japan Jpn J Parasitol 1996; 45: 192200.
  • 13
    Ashitani J, Mukae H, Nakazato M et al. Elevated pleural fluid levels of defensins in patients with empyema. Chest 1998; 113: 78894.
  • 14
    Gonzalo JA, Pan Y, Lloyd CM et al. Mouse monocyte-derived chemokine is involved in airway hyperreactivity and lung inflammation. J Immunol 1999; 163: 40311.
  • 15
    Kawasaki S, Takizawa H, Yoneyama H et al. Intervention of thymus and activation-regulated chemokine attenuates the development of allergic airway inflammation and hyperresponsiveness in mice. J Immunol 2001; 166: 205562.
  • 16
    Sekiya T, Miyamasu M, Imanishi M et al. Inducible expression of a Th2-type CC chemokine thymus- and activation-regulated chemokine by human bronchial epithelial cells. J Immunol 2000; 165: 220513.
  • 17
    Kakinuma T, Nakamura K, Wakugawa M et al. Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and ­activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 2001; 107: 53541.
  • 18
    Mochizuki M, Bartels J, Mallet AI et al. IL-4 induces eotaxin. a possible mechanism of selective eosinophil recruitment in helminth infection and atopy. J Immunol 1998; 160: 608.
  • 19
    Takatsu K, Takaki S, Hitoshi Y. Interleukin-5 and its receptor system: implications in the immune system and inflammation. Adv Immunol 1994; 57: 14590.
  • 20
    Qiu B, Frait KA, Reich F, Komuniecki E, Chensue SW. Chemokine expression dynamics in mycobacterial (type-1) and schistosomal (type-2) antigen-elicited pulmonary granuloma formation. Am J Pathol 2001; 158: 150315.
  • 21
    Miotto D, Christodoulopoulos P, Olivenstein R et al. Expression of IFN-gamma-inducible protein; monocyte chemotactic proteins 1, 3, and 4; and eotaxin in TH1- and TH2-mediated lung diseases. J Allergy Clin Immunol 2001; 107: 66470.
  • 22
    Yamada H, Hirai K, Miyamasu M et al. Eotaxin is a potent chemotaxin for human basophils. Biochem Biophys Res Commun 1997; 231: 3658.
  • 23
    Alam R. Chemokines in allergic inflammation. J Allergy Clin Immunol 1997; 99: 2737.